Valerio Therapeutics Société anonyme Balance Sheet Health
Financial Health criteria checks 0/6
Valerio Therapeutics Société anonyme has a total shareholder equity of €4.0M and total debt of €12.7M, which brings its debt-to-equity ratio to 317%. Its total assets and total liabilities are €29.3M and €25.3M respectively.
Key information
317.0%
Debt to equity ratio
€12.75m
Debt
| Interest coverage ratio | n/a |
| Cash | €4.00m |
| Equity | €4.02m |
| Total liabilities | €25.32m |
| Total assets | €29.34m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0NWK's short term assets (€8.7M) do not cover its short term liabilities (€9.7M).
Long Term Liabilities: 0NWK's short term assets (€8.7M) do not cover its long term liabilities (€15.6M).
Debt to Equity History and Analysis
Debt Level: 0NWK's net debt to equity ratio (217.5%) is considered high.
Reducing Debt: 0NWK's debt to equity ratio has increased from 19% to 317% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0NWK has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0NWK has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.2% each year